Sign in to continue:

Tuesday, February 10th, 2026

Chularat Hospital: Poised for Strong 4Q24 with Higher Revenue per Adjusted RW

Date of Report: October 1, 2024
Broker: CGS-CIMB Securities Malaysia Sdn. Bhd.

Company Overview

Chularat Hospital is a Thailand-based healthcare provider offering a wide range of medical services. The hospital group operates multiple facilities and serves a broad patient base, focusing on delivering quality healthcare services in the region.

Financial Performance

Chularat Hospital is expected to perform well in 4Q24, with anticipated revenue of THB7,200 per adjusted RW (Relative Weight), reflecting strong operational efficiency and an increase in patient volume. The hospital’s financial outlook is promising, driven by improvements in both patient inflow and service offerings.

Revenue Drivers

The revenue growth for Chularat Hospital in the fourth quarter is largely attributed to a rise in the adjusted RW metric. This increase indicates the hospital’s ability to generate higher revenue per patient, which is a positive indicator of the company’s financial health and profitability.

Investment Recommendation

The report maintains an “Add” recommendation for Chularat Hospital, with an increased target price (TP) of THB3.10. The positive outlook is supported by the hospital’s consistent ability to enhance revenue per adjusted RW and its growing patient base, both of which signal long-term growth potential.

Conclusion

Chularat Hospital is poised for a strong 4Q24 performance, with a notable increase in revenue per adjusted RW. This growth, coupled with the hospital’s strong operational framework, supports the “Add” recommendation and revised higher target price of THB3.10. The company’s steady expansion and financial health make it a compelling investment in the healthcare sector.

InnoTek Approved as Tier 1 Supplier to Nvidia: Singapore Market Update, Institutional Fund Flows & Key Dividend Dates (October 2025)

Broker Name: Lim & Tan Securities Date of Report: 13 October 2025 Excerpt from Lim & Tan Securities report. InnoTek Limited has been approved as a recommended vendor for NVIDIA and IEIT Systems, marking...

US and Asia Stock Markets React to Nvidia Earnings, Bumitama Agri Leads Singapore Gains – August 2025 Market Update

OCBC Investment Research Date of Report: 28 August 2025 Global Markets Pulse: Tech Wobbles, Dividend Plays Shine, and Singapore’s Equity Giants in Focus United States: Tech Earnings Jolt Rally as AI Enthusiasm Faces Reality...

CapitaLand Ascendas REIT (CLAR): 1Q25 Occupancy & Rental Analysis

CGS International April 28, 2025 CapitaLand Ascendas REIT (CLAR): Navigating Occupancy Dips with Rental Uplift CLAR 1Q25 Business Update: Key Highlights CapitaLand Ascendas REIT (CLAR) reported a 1.3% point quarter-over-quarter decline in portfolio occupancy,...